Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01050764
What this trial is testing

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Who this might be right for
Leukemia, AcuteChronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)+4 more
Everett Meyer 10
Testing effectiveness (Phase 2)Study completedNCT05009719
What this trial is testing

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Who this might be right for
Hematologic Malignancy
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Study completedNCT02867800
What this trial is testing

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseGraft Versus Host Disease
Monica Bhatia 24
Not applicableActive Not RecruitingNCT05271630
What this trial is testing

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 69
Testing effectiveness (Phase 2)Study completedNCT00793351
What this trial is testing

Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation

Who this might be right for
Neuroblastoma
Samsung Medical Center 25
Early research (Phase 1)Looking for participantsNCT06996119
What this trial is testing

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaGraft Versus Host DiseaseMyelodysplastic Syndrome
City of Hope Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT05969743
What this trial is testing

Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Who this might be right for
Graft-versus-host-diseaseCMV
Rabin Medical Center 42
Early research (Phase 1)Study completedNCT00350818
What this trial is testing

Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 90
Not applicableStudy completedNCT05315882
What this trial is testing

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA

Who this might be right for
CMV Infection
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300
Early research (Phase 1)UnknownNCT05075837
What this trial is testing

Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT

Who this might be right for
Viral Infection After HSCT
Istituto Giannina Gaslini 10
Early research (Phase 1)Study completedNCT01468467
What this trial is testing

AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Daiichi Sankyo 13
Not applicableStudy completedNCT03192319
What this trial is testing

Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation

Who this might be right for
Herpes Zoster
Seoul National University Hospital 86
Testing effectiveness (Phase 2)UnknownNCT05250362
What this trial is testing

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancy
Sichuan University 56
Not applicableUnknownNCT05727917
What this trial is testing

Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 78
Testing effectiveness (Phase 2)Study completedNCT02331368
What this trial is testing

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 32
Large-scale testing (Phase 3)Looking for participantsNCT06202625
What this trial is testing

Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 142
Not applicableUnknownNCT05156554
What this trial is testing

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Lymphoma
Sun Yat-sen University 80
Not applicableEnrolling By InvitationNCT07747194
What this trial is testing

Acupuncture to Prevent Nausea and Vomiting After Stem Cell Transplant

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)Hematopoietic Stem Cell Transplantation (HSCT)
Xiao Wang 80
Large-scale testing (Phase 3)Study completedNCT01321541
What this trial is testing

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Who this might be right for
Diffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more
CTI BioPharma 312
Next Page